J. Moake

J. Moake, O. Frazier, B. Konkle, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Increased von Willebrand factor (vWf) binding to platelets associated with impaired vWf breakdown in thrombotic thrombocytopenic purpura

J. Moake, T. Chow, 1998, Journal of clinical apheresis.

Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura

J. Moake, R. Trompeter, B. Kaplan, 1992 .

Thrombotic Thrombocytopenic Purpura, Hemolytic–Uremic Syndrome, and HELLP

J. Moake, K. Baker, 2011 .

Journey in reverse: TTP from bedside to blood bank to bench

J. Moake, 2007, Journal of clinical apheresis.

Chapter 24 – Thrombotic Thrombocytopenic Purpura

J. Moake, 2007 .

cell secretion and impair ADAMTS-13 cleavage of unusually large von Hemolytic uremic syndrome-associated Shiga toxins promote endothelial

J. Moake, A. Bernardo, T. Cleary, 2013 .

Haemolytic-uraemic syndrome: basic science

J. Moake, 1994, The Lancet.

Telangiectasia and von Willebrand's disease in two families.

J. Moake, J. Olson, R. Weinger, 1978, Annals of internal medicine.

Binding of radioiodinated human von Willebrand factor to Bernard-Soulier, thrombasthenic and von Willebrand's disease platelets.

J. Moake, S. Tang, J. Olson, 1980, Thrombosis research.

Hemolytic anemia associated with multiple autoantibodies and low serum complement.

J. Moake, D. Schultz, 1975, The American journal of medicine.

Effects of Integrelin on platelet function in flow models of arterial thrombosis.

J. Moake, L. McIntire, K. Konstantopoulos, 1997, Journal of cardiovascular pharmacology.

Receptor sites for complement and for immune complexes on human nonhemopoietic tumor cells

J. Moake, H. Biran, G. Mavligit, 1979 .

Thrombotic thrombocytopenic purpura associated with clopidogrel.

W R Bell, J. Moake, M. Feldman, 2000, The New England journal of medicine.

Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies.

J. Moake, 2009, Best practice & research. Clinical haematology.

Thrombotic Microangiopathies: Multimers, Metalloprotease, and Beyond

J. Moake, 2009, Clinical and translational science.

Thrombotic thrombocytopenic purpura: survival by "giving a dam".

J. Moake, 2004, Transactions of the American Clinical and Climatological Association.

Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

J. Moake, Kelty R. Baker, 2000, Current opinion in pediatrics.

Thrombotic thrombocytopenic purpura: the systemic clumping "plague".

J. Moake, 2002, Annual review of medicine.

Report on the workshop: Von Willebrand factor and thrombotic thrombocytopenic purpura

J. Moake, P. Mannucci, J. Sadler, 2001, American journal of hematology.

Spontaneous hyphema associated with ingestion of aspirin and ethanol.

J. Moake, W. Kageler, C. Garcia, 1976, American journal of ophthalmology.

Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma.

J. Moake, K. Moise, R. Carpenter, 1989, Blood.

Thrombotic thrombocytopenic purpura: understanding a disease no longer rare.

J. Moake, T. Chow, 1998, The American journal of the medical sciences.

POSTPARTUM THROMBOTIC THROMBOCYTOPENIC PURPURA COMPLICATED BY BUDD‐CHIARI SYNDROME

J. Moake, M. Belfort, K. Moise, 1995, Obstetrics and gynecology.

Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin

J. Moake, L. Nolasco, N. Stathopoulos, 1988 .

Von Willebrand Factor Multimeric Levels and Patterns in Patients With Severe Preeclampsia

J. Moake, J. Thorp, G. White, 1990, Obstetrics and Gynecology.

ASPIRIN PREVENTS HEPARIN‐INDUCED PLATELET AGGREGATION IN VIVO

J. Moake, G. Carpinito, P. Janson, 1983, British journal of haematology.

Platelet factor 4 does not promote von Willebrand factor binding to human platelets.

J. Moake, S. P. Levine, 1984, Thrombosis research.

Adhesion of human platelets to purified solid-phase von Willebrand factor: studies of normal and Bernard-Soulier platelets.

J. Moake, M. Collins, J. Olson, 1983, Thrombosis research.

Complement activation in vivo in cancer patients receiving C. parvum immunotherapy.

J. Moake, E. Hersh, J. Gutterman, 1976, British Journal of Cancer.

Human endothelial cells and fibroblasts express and produce the coagulation proteins necessary for thrombin generation

J. Moake, N. Turner, C. Cohen, 2021, Scientific Reports.

Interaction of Shiga Toxin with the A-domains and Multimers of von Willebrand Factor*

J. Moake, N. Lo, M. Crúz, 2013, The Journal of Biological Chemistry.

Willebrand Factor A-domains and Multimers of von Interaction of Shiga Toxin with the Protein Structure and Folding :

J. Moake, N. Lo, M. Crúz, 2013 .

Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura

J. Moake, K. Moise, M. Weinstein, 1989, British journal of haematology.

Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura

J. Moake, L. Nolasco, M. Chintagumpala, 1998, American journal of hematology.

Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

J. Moake, P. McPherson, 1989, The American journal of medicine.

Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets.

J. Moake, L. McIntire, A. Schreiber, 1993, Blood.

Inhibition of ristocetin-induced platelet agglutination by vancomycin.

J. Moake, E. Natelson, P. Roper, 1977, Blood.

Acquired Von Willebrand Factor Abnormalities in Adults with Congenital Heart Disease: Dependence Upon Cardiopulmonary Pathophysiological Subtype

J. Moake, M. Territo, J. Perloff, 1998 .

Fibrinogen houston: A dysfibrinogen exhibiting defective fibrin monomer aggregation and α‐chain cross‐linkages

J. Moake, R. Weinger, C. Rudy, 1980, American journal of hematology.

Isolation from commercial aurintricarboxylic acid of the most effective polymeric inhibitors of von Willebrand factor interaction with platelet glycoprotein Ib. Comparison with other polyanionic and polyaromatic polymers.

J. Moake, E. Vosburgh, M. Weinstein, 1991, Blood.

Aurin tricarboxylic acid: a novel inhibitor of the association of von Willebrand factor and platelets.

J. Moake, L. Nolasco, N. Turner, 1988, Blood.

Platelets in bloom.

J. Moake, 2010, Blood.

Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura

J. Moake, J. Byrnes, P. Klug, 1990, American journal of hematology.

Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathioprine

J. Moake, A. Schafer, M. Weinstein, 1985, American journal of hematology.

Complement activation in thrombotic microangiopathies

J. Moake, L. Nolasco, M. Kroll, 2013, British journal of haematology.

Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission.

J. Moake, M. Chintagumpala, R. Hurwitz, 1992, The Journal of pediatrics.

A novel flow cytometric analysis for platelet activation on immobilized von Willebrand factor or fibrillar collagen

J. Moake, L. McIntire, N. Turner, 2003, Journal of thrombosis and haemostasis : JTH.

Diagnostic Criteria for Hematopoietic Stem Cell Transplantation-Associated Microangiopathy (TAM): Results of a Consensus Process by an International Working Group.

J. Moake, J. George, B. Lämmle, 2005 .

Thrombotic microangiopathies associated with drugs and bone marrow transplantation.

J. Moake, J. Byrnes, 1996, Hematology/oncology clinics of North America.

von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

J. Moake, P. McPherson, 1990, Transfusion medicine reviews.

ADAMTS‐13 cleaves long von Willebrand factor multimeric strings anchored to endothelial cells in the absence of flow, platelets or conformation‐altering chemicals

J. Moake, L. Nolasco, N. Turner, 2009, Journal of thrombosis and haemostasis : JTH.

Defective processing of unusually large von Willebrand factor multimers and thrombotic thrombocytopenic purpura

J. Moake, 2004, Journal of thrombosis and haemostasis : JTH.

ADAMTS‐13 activity in plasma is rapidly measured by a new ELISA method that uses recombinant VWF‐A2 domain as substrate

J. Moake, A. Bernardo, L. Nolasco, 2004, Journal of thrombosis and haemostasis : JTH.

Case Series of Thrombotic Thrombocytopenic Purpura in Children and Adolescents

J. Moake, T. Horton, Z. Dreyer, 2003, Journal of pediatric hematology/oncology.

Thrombotic thrombocytopenic purpura today.

J. Moake, 1999, Hospital practice.

Studies on the pathophysiology of thrombotic thrombocytopenic purpura.

J. Moake, 1997, Seminars in hematology.

Abnormalities of von willebrand factor multimers in drug‐associated thrombotic microangiopathies

J. Moake, J. Hester, D. Charba, 1993, American journal of hematology.

Cryosupernatant regulates accumulation of unusually large vWF multimers from endothelial cells.

J. Moake, L. Nolasco, L. McIntire, 1989, The American journal of physiology.

von Willebrand factor (vWF) abnormalities in thrombotic thrombocytopenic purpura (TTP) and the hemolytic uremic syndrome (HUS)

J. Moake, 1992 .

Familial Infantile Thrombotic Thrombocytopenic Purpura

J. Moake, J. Jimenez, A. Yunis, 1996, Journal of pediatric hematology/oncology.

Thrombotic Thrombocytopenic Purpura

J. Moake, J. Moake, 1995, Thrombosis and Haemostasis.

Novel ADAMTS‐13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura

J. Moake, L. Nolasco, L. Rice, 2006, Journal of thrombosis and haemostasis : JTH.

Direct Detection of Red Blood Cell Fragments: A New Flow Cytometric Method to Evaluate Hemolysis in Blood Pumps

J. Moake, J. Linneweber, Y. Nosé, 2001, ASAIO journal.

THE RESPONSE OF HUMAN PLATELETS TO SHEAR STRESS AT SHORT EXPOSURE TIMES

J. Moake, C. Alfrey, Alfrey Cp, 1977, Transactions - American Society for Artificial Internal Organs.

Studies on the Mechanisms of Shear-Induced Platelet Activation

Todd D. Giorgio, J. Moake, N. Stathopoulos, 1987 .

Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa.

J. Moake, N. Stathopoulos, J. D. Hellums, 1987, Blood.

Bernard‐Soulier Disease: a Study of Four Patients and their Parents

J. Moake, J. George, D. Sears, 1981, British journal of haematology.

Granulocyte proteases do not process endothelial cell‐derived unusually large von willebrand factor multimers to plasma vWF in vivo

J. Moake, L. Nolasco, M. Phillips, 1991, American journal of hematology/oncology.

Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells

J. Moake, N. Turner, S. Sartain, 2018, The Journal of Biological Chemistry.

TNF Regulates Essential Alternative Complement Pathway Components and Impairs Activation of Protein C in Human Glomerular Endothelial Cells

J. Moake, N. Turner, S. Sartain, 2016, The Journal of Immunology.

Ultralarge von Willebrand factor-induced platelet clumping and activation of the alternative complement pathway in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndromes.

J. Moake, N. Turner, S. Sartain, 2015, Hematology/oncology clinics of North America.

Thrombotic Microangiopathies and the Linkage between von Willebrand Factor and the Alternative Complement Pathway

J. Moake, L. Nolasco, N. Turner, 2014, Seminars in Thrombosis & Hemostasis.

Assembly and Activation of Alternative Complement Components on Endothelial Cell-Anchored Ultra-Large Von Willebrand Factor Links Complement and Hemostasis-Thrombosis

J. Moake, N. Turner, 2013, PloS one.

Vancomycin effect on thrombin-induced platelet aggregation: evidence against a common platelet membrane receptor for thrombin and ristocetin.

J. Moake, R. Weinger, 1978, Thrombosis research.

Hairy cell leukemia in association with thrombotic thrombocytopenic purpura and factor VIII antibodies.

J. Moake, N. Wisch, S. Lichtman, 1996, Leukemia & lymphoma.

Solvent/detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura.

J. Moake, L. Nolasco, M. Chintagumpala, 1994, Blood.

Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.

J. Moake, L. Nolasco, N. Stathopoulos, 1986, The Journal of clinical investigation.

Mg2+-dependent, (Na+ + K+)-stimulated ATPase of human platelets: Properties and inhibition by ADP

J. Moake, N. Bachur, K. Ahmed, 1970 .

Intravascular hemolysis, thrombocytopenia, leukopenia, and circulating immune complexes after jejunal-ileal bypass surgery.

J. Moake, R. Rossen, W. Kageler, 1977, Annals of internal medicine.

Sickle cell--betao thalassemia variant with high hemoglobin F and mild clinical course.

J. Moake, J. Shaeffer, 1976, The American journal of medicine.

Generation and Breakdown of Soluble Ultralarge von Willebrand Factor Multimers

J. Moake, L. Nolasco, N. Turner, 2012, Seminars in Thrombosis & Hemostasis.

Morphine-induced immune thrombocytopenia.

J. Moake, J. Hammond, P. Cimo, 1982, Archives of internal medicine.

Severe proliferative retinopathy as the only sign of sickle cell hemoglobin C disease.

J. Moake, R. S. Ruiz, W. M. Cooper, 1976, American journal of ophthalmology.

von Willebrand factor binding to platelet GpIb initiates signals for platelet activation.

J. Moake, T. Harris, M. Kroll, 1991, The Journal of clinical investigation.

Production and control of coagulation proteins for factor X activation in human endothelial cells and fibroblasts

J. Moake, N. Turner, C. Cohen, 2020, Scientific Reports.

Factor VIII Is Synthesized in Human Endothelial Cells, Packaged in Weibel-Palade Bodies and Secreted Bound to ULVWF Strings

J. Moake, N. Turner, 2015, PloS one.

Regulatory Components of the Alternative Complement Pathway in Endothelial Cell Cytoplasm, Factor H and Factor I, Are Not Packaged in Weibel-Palade Bodies

J. Moake, N. Turner, S. Hui, 2015, PloS one.

Laminin Peptide-Immobilized Hydrogels Modulate Valve Endothelial Cell Hemostatic Regulation

K., J. Moake, H. Tseng, 2015, PloS one.

Direct demonstration of radiolabeled von willebrand factor binding to platelet glycoprotein Ib and IIb-IIIa in the presence of shear stress

J. Moake, L. Nolasco, J. D. Hellums, 1995, Annals of Biomedical Engineering.

Recent observations on the pathophysiology of thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

J. Moake, 1990, Hematologic pathology.

Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.

J. Moake, J. Byrnes, 1986, Clinics in haematology.

Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers.

Bahman Anvari, Larry V McIntire, Maneesh Arya, 2002, Blood.

Investigating intermolecular forces associated with thrombus initiation using optical tweezers

Bahman Anvari, Maneesh Arya, Gabriel M. Romo, 2002, SPIE BiOS.

Ultra-Large Multimers of Von Willebrand Factor form Spontaneous High-Strength Bonds with the Platelet GP Ib-IX Complex : Studies using Optical Tweezers

J. Moake, L. McIntire, B. Anvari, 2002 .

von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.

J. Moake, 2004, Seminars in hematology.

Genome-wide DNA methylation profiling predicts relapse in childhood B-cell acute lymphoblastic leukaemia

J. Moake, L. Nolasco, M. Kroll, 2013 .

Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group.

J. Moake, J. George, B. Lämmle, 2007, Haematologica.

Recent advances in thrombotic thrombocytopenic purpura.

J. Moake, J. George, T. Miyata, 2004, Hematology. American Society of Hematology. Education Program.

ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.

Kazuo Fujikawa, Larry V McIntire, J. Moake, 2002, Blood.

Fibrillin Containing Elastic Microfibrils Support Platelet Adhesion under Dynamic Shear Conditions

J. Moake, L. McIntire, R. Glanville, 1998, Thrombosis and Haemostasis.

J D Hellums, J. Moake, L. Nolasco, 1988, Blood.

Platelet response to shear stress: changes in serotonin uptake, serotonin release, and ADP induced aggregation.

J. Moake, J. D. Hellums, C. Alfrey, 1978, Thrombosis research.

Shear stress-induced binding of von Willebrand factor to platelets.

J. Moake, K. Konstantopoulos, J. D. Hellums, 1997, Biorheology.

Platelet lysis and aggregation in shear fields.

J D Hellums, J. Moake, J. D. Hellums, 1978, Blood cells.

Alterations in Hemostatic Parameters During Hemodialysis With Dialyzers of Different Membrane Composition and Flow Design. Platelet Activation and Factor VIII-Related von Willebrand Factor During Hemodialysis

J. Moake, R. Hamburger, G. Schmitt, 1988 .

Differential Effects of Cytochalasin B on Platelet Release, Aggregation and Contractility: Evidence against a Contractile Mechanism for the Release of Platelet Granular Contents

J. Moake, L. McIntire, J. Kirkpatrick, 1979, Thrombosis and Haemostasis.

Thrombotic Thrombocytopenic Purpura and Related Thrombotic Microangiopathies

J. Moake, Junmei Chen, José A López, 2013 .

Thrombotic thrombocytopenic purpura

Karen Vanhoorelbeke, Paul Coppo, J. Moake, 2017, Nature Reviews Disease Primers.

Attack of the acronyms: TTP, VWF, ADAMTS‐13 and SELDI‐TOF‐MS

J. Moake, M. Auton, Matthew Auton, 2006, Journal of thrombosis and haemostasis : JTH.

Severe hemolysis and red cell fragmentation caused by the combination of a spectrin mutation with a thrombotic microangiopathy

J. Moake, J. Lawler, H. Jacob, 1989, American journal of hematology.

Acquired von Willebrand syndrome associated with left ventricular assist device.

J. Moake, S. Neelamegham, O. Frazier, 2016, Blood.

P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface.

J. Moake, A. Bernardo, C. Ball, 2004, Blood.

Streptokinase-induced degradation of crosslinked and uncrosslinked clots.

J. Moake, L. McIntire, J. Kirkpatrick, 1978, Thrombosis research.

Receptor sites for complement and for immune complexes on human nonhemopoietic tumor cells.

J. Moake, H. Biran, G. Mavligit, 1979, Cancer.

Platelets, von Willebrand factor, and prostaglandin I2.

J. Moake, P. Davies, S. Tang, 1981, The American journal of physiology.

Direct detection of red blood cell fragments: a new flow cytometric method to evaluate hemolysis in blood pumps.

J. Moake, J. Linneweber, Y. Nosé, 2000 .

The effect of PGI2 and theophylline on the response of platelets subjected to shear stress.

J. Moake, J. D. Hellums, D. Peterson, 1981, Blood.

Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.

J. Moake, L. McIntire, R. Jordan, 1995, Circulation.

Human Complement Factor H Is a Reductase for Large Soluble von Willebrand Factor Multimers—Brief Report

J. Moake, L. Nolasco, S. Feng, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Mechanical activation of a multimeric adhesive protein through domain conformational change.

Eric W. Frey, J. Moake, L. Nolasco, 2013, Physical review letters.

Enhanced platelet adhesion and aggregation by endothelial cell-derived unusually large multimers of von Willebrand factor.

J. Moake, L. Nolasco, L. McIntire, 2006, Biorheology.

Bilateral combined occlusion of the central retinal artery and vein secondary to thrombotic thrombocytopenic purpura.

J. Moake, W. Mieler, S. G. Schwartz, 2000, Archives of ophthalmology.

In Vitro Comparison of Blood Pump Induced Platelet Microaggregates between a Centrifugal and Roller Pump During Cardiopulmonary Bypass

J. Moake, J. Linneweber, Y. Nosé, 2002, The International journal of artificial organs.

Unusually Largevon Willebrand FactorMultimers Increase AdhesionofSickle Erythrocytes toHumanEndothelial CellsunderControlled Flow

J. Moake, T. Wick, andLarryV . McIntire, 1987 .

Intrathoracic extramedullary hematopoiesis: report of a case in a patient with sickle-cell disease-beta-thalassemia.

J. Moake, J L Moake, R Verani, 1980, American journal of clinical pathology.

Heat-inactivated Factor B inhibits alternative pathway fluid-phase activation and convertase formation on endothelial cell-secreted ultra-large von Willebrand factor strings

J. Moake, N. Turner, 2023, Scientific Reports.

Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions

J. Moake, L. Nolasco, J. Voorberg, 2008, Journal of thrombosis and haemostasis : JTH.

Platelets adhered to endothelial cell‐bound ultra‐large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress

J. Moake, A. Bernardo, C. Ball, 2005, Journal of thrombosis and haemostasis : JTH.

Thermodynamic Analysis of Von Willebrand Disease Type 2B and 2M Mutations on the Structural Stability of the Von Willebrand Factor A1 Domain.

J. Moake, E. Sedlák, M. Auton, 2008 .

Rheological studies of the contractile force within platelet-fibrin clots: effects of prostaglandin E1, dibutyryl-cAMP and dibutyryl-cGMP.

J. Moake, L. McIntire, M. Kuntamukkula, 1978, Thrombosis research.

Effects of colchicine and vinblastine on platelet contractility and release.

J. Moake, L. McIntire, M. Kuntamukkula, 1982, Thrombosis research.

Haemolytic-uraemic syndrome: basic science.

J. Moake, 1994 .

Type IIB von Willebrand's disease: unusual response to cryoprecipitate infusion.

J. Moake, J. Olson, R. Weinger, 1981, Annals of internal medicine.

Clot retraction: evaluation in dilute suspensions of platelet-rich plasma and gel-separated platelets.

J. Moake, Y. Yeo, J. Reynolds, 1976, The Journal of laboratory and clinical medicine.

The effect of PGI2 and theophylline on the response of platelets subjected to shear stress

J. Moake, J. D. Hellums, J. Olson, 1981 .

Effects of Prostaglandins, Derivatives of Cyclic 3':5'-AMP, Theophylline, Cholinergic Agents and Colchicine on Clot Retraction in Dilute Platelet-Rich Plasma and Gel-Separated Platelet Test Systems

J. Moake, J. Gum, D. Peterson, 1977, Thrombosis and Haemostasis.

Measurement of von Willebrand factor cleaving protease (ADAMTS‐13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas

J. Moake, K. Friedman, A. Tripodi, 2004, Journal of thrombosis and haemostasis : JTH.

Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination.

J. Moake, J. Olson, R. Weinger, 1980, The Journal of laboratory and clinical medicine.

Thrombotic microangiopathies [4] (multiple letters)

J. Moake, P. Tarr, W. Chandler, 2002 .

In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology.

J. Moake, W. Lam, D. Fletcher, 2012, The Journal of clinical investigation.

Correlating Conformational Dynamics with the Von Willebrand Factor Reductase Activity of Factor H Using Single Molecule Force Measurements.

J. Moake, L. Nolasco, C. Kiang, 2018, The journal of physical chemistry. B.

Insolubilized von Willebrand factor and the initial events in hemostasis.

J. Moake, 1989, The Journal of laboratory and clinical medicine.

Human Complement Factor H Is a Reductase for Large Soluble von Willebrand Factor Multimers—Brief Report

J. Moake, L. Nolasco, S. Feng, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Receptor sites for complement and for immune complexes on human nonhemopoietic tumor cells

J. Moake, H. Biran, Giona M. Mavligit, 1979, Cancer.

CHAPTER 50 – Thrombotic Thrombocytopenic Purpura and the Hemolytic-Uremic Syndrome

J. Moake, J. Moake, K. Baker, 2007 .

Thrombotic Thrombocytopenic Purpura and Related Thrombotic Microangiopathies

J. Moake, Junmei Chen, H. T. Özpolat, 2019, Consultative Hemostasis and Thrombosis.

Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage.

J. Moake, L. Nolasco, Z. Ruggeri, 2009, Blood.

Correlation of ADAMTS-13 Activity with Response to Plasma Exchange in Patients Diagnosed with Thrombotic Thrombocytopenic Purpura.

J. Moake, L. Nolasco, José A López, 2004 .

Effects of antiplatelet agents on platelets exposed to shear stress.

J. Moake, C. Alfrey, D. Peterson, 1980, Transactions - American Society for Artificial Internal Organs.

Shear Stress-Induced Binding of Large and Unusually Large von Willebrand Factor to Human Platelet Glycoprotein Ibα

J. Moake, L. McIntire, José A López, 2004, Annals of Biomedical Engineering.

aggregation and prevents episodes of thrombotic thrombocytopenic Solvent/detergent-treated plasma suppresses shear-induced platelet

J. Moake, L. Nolasco, M. Chintagumpala, 2011 .

Platelets in bloom.

J. Moake, 2010, Blood.

Circulating IgG antibodies against factors IX and VIII in multiple sclerosis.

J. Moake, C. Kent, L. Wright, 1976, Acta haematologica.

Reversal by adenosine of ADP inhibition of platelet (Na+ + K+)-ATPase.

J. Moake, N. Bachur, K. Ahmed, 1970, Biochimica et biophysica acta.